Program Director
Principal Investigator
Jon David
Levine
Awardee Organization
University Of California, San Francisco
United States
Fiscal Year
2022
Activity Code
R01
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date
NIH RePORTER
For more information, see NIH RePORTER Project 5R01CA250017-04
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress
No abstract provided
Publications
- Ferrari LF, Araldi D, Green PG, Levine JD. Marked sexual dimorphism in neuroendocrine mechanisms for the exacerbation of paclitaxel-induced painful peripheral neuropathy by stress. Pain. 2020 Apr;161(4):865-874. PMID: 31917777
- Staurengo-Ferrari L, Green PG, Araldi D, Ferrari LF, Miaskowski C, Levine JD. Sexual dimorphism in the contribution of neuroendocrine stress axes to oxaliplatin-induced painful peripheral neuropathy. Pain. 2021 Mar 1;162(3):907-918. PMID: 32947545
- Staurengo-Ferrari L, Bonet IJM, Araldi D, Green PG, Levine JD. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2022 Jan 19;42(3):405-415. Epub 2021 Dec 8. PMID: 34880120
- Bonet IJM, Staurengo-Ferrari L, Araldi D, Green PG, Levine JD. Second messengers mediating high-molecular-weight hyaluronan-induced antihyperalgesia in rats with chemotherapy-induced peripheral neuropathy. Pain. 2022 Sep 1;163(9):1728-1739. Epub 2021 Dec 6. PMID: 34913881
- Bonet IJM, Araldi D, Bogen O, Levine JD. Involvement of TACAN, a Mechanotransducing Ion Channel, in Inflammatory But Not Neuropathic Hyperalgesia in the Rat. The journal of pain. 2021 May;22(5):498-508. Epub 2020 Nov 21. PMID: 33232830